Imatinib
In Stock•Starting at $8 for 1 g•Purity ≥ 98%
| CAS No. | 152459-95-5 |
|---|---|
| MDL No. | MFCD05662257 |
| MF | C29H31N7O |
| MW | 493.60 |
| InChI Key | KTUFNOKKBVMGRW-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 g | 98% | $8 | In Stock | |
| 5 g | 98% | $12 | In Stock | |
| 10 g | 98% | $21 | In Stock | |
| 25 g | 98% | $33 | In Stock | |
| 100 g | 98% | $116 | In Stock |
Product Information
Imatinib is a benzamide formed by the formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary aromatic amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine. It is used as its mesylate salt in the treatment of chronic myelogenous leukemia and gastrointestinal stromal tumors. It functions as an apoptosis inducer, tyrosine kinase inhibitor, and antineoplastic agent. It is a N-methylpiperazine, a pyridine, a benzamide, an aromatic amine, and a pyrimidine. It is functionally related to benzamides.
| CAS No. | 152459-95-5 |
|---|---|
| Product Name | Imatinib |
Biological Targets
ABL1·BCR·PDGFRB·KIT
Associated Conditions
acute myeloid leukemia·colonic neoplasm·male breast carcinoma·thyroid cancer·systemic scleroderma·
* The information provided here is compiled from public sources and is for reference only.
